Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
UN panel says Israel operating 'de facto policy of torture' - 2Geomagnetic storm grounds launch of Mars space weather satellites
- 3Figure out How to Amplify the Resale Worth of Your Kona SUV
- 4'Yellowstone' made him a fan favorite. His biggest role isn't the one you see.
- 5Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- Instructions to Upgrade the Proficiency of Your Sunlight powered chargers
- Avoid Slam: Exploring the Pickup Truck Transformation
- Figure out How to Back Your Rooftop Substitution
- Banks for High Fixed Store Rates: Augment Your Investment funds
- Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
- Illumina unveils dataset to speed up AI-powered drug discovery
- Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- Finding the Universe of Computer generated Reality: Individual Encounters
- Top 20 Compelling Business Books for Progress
